Peptide Research Collection Library
Explore the compound
Quick Facts
Mechanism of Action
VIP is vasoactive intestinal peptide, a 28-amino-acid neuropeptide. Its mechanism activates VPAC receptors involved in vasodilation, immune modulation, gut signaling, and pulmonary research pathways.
Mechanism of Action: activates VPAC receptors involved in vasodilation, immune modulation, gut signaling, and pulmonary research pathways.
- Supports immune-modulation and inflammation-balance pathways described in biomedical literature [1].
- Commonly discussed for recovery, immune resilience, tissue protection, or antimicrobial-defense research depending on peptide [1].
- Associated with cytokine, innate-immunity, and cellular-protection endpoints in NIH-indexed research [1].
- Official clinical-trial and PubMed records provide the research backbone for this peptide category [1][2].
Research Applications & Context
Community-reported protocol schedules.
Research Dosage Information
Reported research quantities and their source context. These are not recommendations, and source status varies.
Scroll the table horizontally to read every column. Select a row to inspect it in the calculator.
Conservative Start: 50 mcg Once daily. 1-2 weeks. Standard Research Dose: 100 mcg Twice daily. Ongoing. Advanced Research Dose: 200 mcg Twice daily. Ongoing. Clinic-Style Protocol: 200 mcg 5 times weekly. Ongoing.
| Phase | Reported Amount | Frequency | Draw Units | Cycle | Notes | Calculator |
|---|---|---|---|---|---|---|
| Conservative Star | 50 mcg | Once daily | Select a vial | 1-2 weeks | Community-reported protocol. | |
| Standard Research Dose | 100 mcg | Twice daily | Select a vial | Ongoing | Community-reported protocol. | |
| Advanced Research Dose | 200 mcg | Twice daily | Select a vial | Ongoing | Community-reported protocol. | |
| Clinic-Style Protocol | 200 mcg | 5 times weekly | Select a vial | Ongoing | Community-reported protocol. |
Dosing Protocol & Schedule
These are mathematical planning summaries derived from reported rows already in the research library. Community-reported schedules are not clinical or validated protocols, recommendations, or directions for human use.
| Include | Phase | Research Dose | Frequency | Weeks | Entries | Total quantity | Volume per entry | U-100 equivalent |
|---|---|---|---|---|---|---|---|---|
| Conservative Star | 50 mcg | Once daily | 2 | — | — | — | — | |
| — | Standard Research Dose | 100 mcg | Twice daily | — | — | Duration not specified as a fixed number of weeks. | — | — |
| — | Advanced Research Dose | 200 mcg | Twice daily | — | — | Duration not specified as a fixed number of weeks. | — | — |
| — | Clinic-Style Protocol | 200 mcg | 5 times weekly | — | — | Duration not specified as a fixed number of weeks. | — | — |
Plan a Regimen Schedule
Save the selected research protocol to your private calendar. Scheduled entries never create Dose Logs.
Reconstitution Calculator
Select the vial strength you are examining. The reference chart displays examples, not recommended preparation volumes or validated protocols.
Reconstitution Reference Chart
Hypothetical volume comparisons for the selected vial. No particular volume is endorsed, and vial capacity, solubility, excipients and product-specific instructions are not established by this table.
| Example volume | Calculated concentration | Calculator |
|---|---|---|
| 1 mL | — | |
| 2 mL | — | |
| 3 mL | — | |
| 4 mL | — | |
| 5 mL | — |
Choose a compatible dry vial to see reference concentrations.
Research-only mathematical comparisons; not instructions to compound, prepare, or administer peptides. Community-reported protocols are not clinically validated by inclusion here.
Supplies Needed — Estimate
Select a vial strength and an example reconstitution volume below. Counts use only the checked, computable rows above; they are not product-specific sterility, compatibility, or stability guidance.
Select a compatible vial and volume below to view quantities.
Educational and entertainment purposes only. Research use only; not for human or animal administration. Pad counts assume two per Total entry; syringe counts include additional containers where a single entry exceeds the selected syringe capacity. Vial totals assume full theoretical recovery and do not account for dead volume, spoilage, asepsis, expiration, potency, route, or beyond-use dating. These figures are not a recommended supplies list for an actual procedure.
Published References (0 identified)
A recorded identifier identifies a publication; it does not establish that its claims have been independently verified.
Research indexes & other source links
Searches, registries and unverified source records are discovery resources, not verified published studies.
- PubMed.gov biomedical literature: VIP View source ↗ PubMed index/search · Source link recorded; claim verification separate
- ClinicalTrials.gov study registry: VIP View source ↗ ClinicalTrials.gov registry/search · Source link recorded; claim verification separate
- NIH/NCBI all-databases search: VIP View source ↗ NCBI database/search · Source link recorded; claim verification separate
- PubChem / NIH compound record search: VIP View source ↗ PubChem database/search · Source link recorded; claim verification separate
